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Abstract
Background: Variation in outcomes of patients with community acquired pneumonia (CAP) has been reported in
some, but not all, studies. Although some variation is expected, unwarranted variation in healthcare impacts patient
outcomes and equity of care. The aim of this systematic review was to: i) summarise current evidence on regional
and inter-hospital variation in the clinical outcomes and process of care measures of patients hospitalised with CAP
and ii) assess the strength of this evidence.
Methods: Databases were systematically searched from inception to February 2018 for relevant studies and data
independently extracted by two investigators in accordance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) statement. Included studies enrolled adults hospitalised with CAP and reported
a measure of variation between two or more units in healthcare outcomes or process of care measures. Outcomes
of interest were mortality, length of hospital stay (LOS) and re-admission rates. A structured synthesis of the studies
was performed.
Results: Twenty-two studies were included in the analysis. The median number of units compared across studies
was five (IQR 4–15). Evidence for variation in mortality between units was inconsistent; of eleven studies that
performed statistical significance testing, five found significant variation. For LOS, of nine relevant studies, all found
statistically significant variation. Four studies reported site of admission accounted for 1–24% of the total observed
variation in LOS. A shorter LOS was not associated with increased mortality or readmission rates. For readmission,
evidence was mixed; of seven studies, 4 found statistically significant variation. There was consistent evidence for
variation in the use of intensive care, obtaining blood cultures on admission, receiving antibiotics within 8 h of
admission and duration of intravenous antibiotics. Across all outcome measures, only one study accounted for
natural variation between units in their analysis.
Conclusion: There is consistent evidence of moderate quality for significant variation in length of stay and process
of care measures but not for in-patient mortality or hospital re-admission. Evidence linking variation in outcomes
with variation in process of care measures was limited; where present no difference in mortality was detected
despite POC variation. Adjustment for natural variation within studies was lacking; the proportion of observed
variation due to chance is not quantified by existing evidence.
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Introduction
Geographical variation in clinical care is considered ubi-
quitous across all aspects of healthcare. A proportion of
variation in healthcare measures is warranted, reflecting
true differences in individual healthcare preferences and
the needs of the local population served. Conversely,
persistent unwarranted variation in clinical care directly
impacts on equity of services, population outcomes and
use of resources [1]. Equitable care across geographical
regions has been highlighted as a key concern from a pa-
tient viewpoint [2]. Inevitably, outcome measures are in-
creasingly used to rank healthcare between regions and
hospital providers [3]. However, there is concern that
such ranking does not account for natural variation be-
tween units and may not be reflective of true variation
in quality of healthcare [4].
Community acquired pneumonia (CAP) remains a
major cause of hospitalisation and mortality globally. In
Europe it is estimated that the direct costs of pneumonia
amount to 2.5 billion Euros per annum with the majority
of this cost comprised of inpatient care [5]. Inter-
hospital variation in outcomes of patients hospitalised
with CAP was first suggested from retrospective claims-
based studies in the USA [6]. More recent evidence from
large GP databases in the UK have shown that mortality
for patients under the age of 75 varies up to nine-fold
depending on the geographical location [2]. Little is
known about the causes of this apparent geographical
variation, whether it extends to other outcomes or
process of care measures and to what extent it is
unwarranted.
The aim of this systematic review was to collate avail-
able evidence on regional and inter-hospital variation in
the clinical outcomes and process of care measures of
patients hospitalised with CAP and assess the strength
of this evidence. Where possible, we also sought to iden-
tify any potential causes for any observed variation.
Methods
We systematically searched online databases (MEDLINE,
EMBASE, Web of Science) using Medical Subject head-
ing (MeSH) terms to identify published and unpublished
studies that compared the process of care measures and
outcomes of adults hospitalised with CAP between two
or more hospitals or geographical regions. As MeSH
terms to identify variation excessively limited our search,
we also broadened the search strategy to capture all
studies on adults hospitalised with community-acquired
pneumonia for title screening (Additional Material
Appendix A). Databases were searched from inception
to February 2018 inclusive. Title, abstract and full text
screening were performed in a three-step process by two
independent reviewers (HL, TM) using the online plat-
form Covidence©. Disagreements were resolved by
discussion and involvement of a third reviewer. Hand
searching of references from the list of eligible studies for
further references not identified in the initial search was
performed. Data extraction was performed by each reviewer
(HL, TM) independently using a standardised form. The re-
view was conducted and reported in accordance with the
Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) statement, [7] and prospectively
registered on PROSPERO (CRD42019124068).
All prospective and retrospective observational or ran-
domised controlled studies in any language with no date
restriction on publication were considered for inclusion.
Studies were included if they enrolled adults (> 16 years
old) hospitalised with CAP and reported a measure of
variation between two or more hospitals or geographic-
ally distinct areas in chosen outcome or process of care
measures. For the purpose of this review, included stud-
ies defined CAP either; a) clinically as the acute onset of
symptoms suggestive of lower respiratory tract infection
with new infiltrates on thoracic imaging consistent with
pneumonia or b) using recognised International Classifi-
cation of Disease (ICD) codes pertaining to pneumonia
from administrative databases. Geographical units for
comparison were defined as geographical regions or geo-
graphically separated hospitals serving distinct patient
populations. Measures of inter-hospital variability in-
cluded appropriate descriptive statistics, variance ana-
lysis and graphical methods for comparing institutional
performance.
Studies were excluded if: 1) they enrolled solely im-
munosuppressed patients with Human Immunodefi-
ciency Virus (HIV) and Pneumocystis Pneumonia (PCP)
2) they enrolled patients exclusively from a primary care
setting or 3) they examined temporal variation in CAP
care only. Finally, studies that described or measured
implementation of a change from usual care within a
hospital setting, for example implementation of a pneu-
monia care pathway or an alternative antimicrobial re-
gime, were also excluded.
Primary outcome measures of interest were case mor-
tality, length of hospital stay and hospital re-admission
rates. In accordance with recognised guidelines for the
management of CAP, process of care measures of inter-
est were: a) use of guideline adherent antibiotics; b) ad-
mission rates to intensive care units; c) duration of
antibiotic treatment (both intravenous and total); d) time
to first antibiotic and e) obtaining admission blood cul-
tures [8, 9].
Statistical analysis
Due to differences in the statistical methods used to
evaluate variation across the included studies, a pooled
meta-analysis was not possible. Instead, a structured syn-
thesis of the studies was performed by collating: 1) inter-
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hospital ranges for outcome and process of care mea-
sures, 2) variance analysis and 3) statistical methods to
quantify or control for natural variation between units.
Assessment of Bias
Two reviewers (HL & TM) assessed the methodological
quality of studies using a modified quality score based
on the Newcastle-Ottawa Scale. This score assesses the
risk of bias at outcome level in observational studies in 3
domains: participant selection, comparability of groups
and validity of outcome domains. The maximum score
on the modified scale used was 10.
Results
Comprehensive searching identified 5738 papers. Fol-
lowing title and abstract screening, 88 studies were in-
cluded in the full text assessment, from which 67 studies
were excluded; the main reason for exclusion was the
lack of reporting on variation (Additional Figure 1, add-
itional material). One study was identified following
hand searching of references and subsequently included
in the review [10].
Characteristics of included studies
Twenty-two papers met the inclusion criteria [10–31].
Results from two papers were derived from the same
study population and were combined for further analysis
[26, 28]. A further two papers reported results from the
same population but different measures, so were both
included [19, 25]. Details and characteristics of included
studies with a description of variation between units
compared, their respective populations and disease char-
acteristics are shown in Table 1.
Studies differed in design: seventeen were cohort studies
(nine retrospective, seven prospective and one mixed),
three were analyses of administrative data, [11, 23, 31] one
was a case control study [21] and one study analysed the
baseline population from a randomised control trial [29].
The median number of units compared across studies was
five (IQR 4–15) with a median of 1022 (IQR 445–2009)
cases of CAP. Four studies compared geographical re-
gions, the remaining 18 compared hospitals. Retrospective
cohort studies compared a greater number of units (range
3–38) than prospective cohort studies; the latter involved
a maximum of four units.
The range of quality scores was 5–9.5 (mean 6.95, SD
1.45). The three commonest factors missing from the
quality score were: no statement accounting for missing
data, limited inter-hospital case-mix adjustment for clin-
ical parameters or baseline characteristics and the ab-
sence of a financial or affiliation statement. Baseline
characteristics of study cohorts were not always compar-
able. For example, two prospective cohort studies com-
pared study populations with widely different health care
resources and baseline characteristics [27, 30]. In
addition, there were three international studies [12, 13,
30]; observed variation in these may reflect differences
in international healthcare provision and use.
Variation in outcome measures
Fourteen studies reported variation in in-patient mortality
[10, 12–16, 18, 20–23, 27, 30, 31]. The mean mortality for
each study ranged between 1.1 and 22.6%. The magnitude
of the observed range in variation for in-patient mortality
was between 1 and 18.6% across studies (n= 14, mean 8.4%,
SD 6.1). Of eleven studies that performed statistical signifi-
cance testing, five found statistically significant variation
(Fig. 1a and Additional Table 1) [12, 14, 18, 23, 31]. All 6
studies that did not find statistically significant variation in
inpatient mortality compared 5 or fewer units [10, 15, 21,
22, 27, 30]. One study adjusted for natural variation between
hospitals; Aelvoet et al. used the Spiegaelhalter method to
produce funnel plots examining variation in standardised
mortality ratios (SMRs) across 111 hospitals in Belgium
[11]. Their primary model identified five institutions as ‘pos-
sibly better performing’, 7 as ‘possibly worse performing’
and 81 as ‘normally performing’ with the remaining 18 in an
inconclusive ‘to be assessed’ category, with subsequent sensi-
tivity analysis confirming these findings.
Mortality following discharge was reported by fewer
studies (n = 8); one study reported mortality 14 days post
discharge, [14] six reported 30-day post-admission mor-
tality [15, 17, 19, 22, 27, 31] and one reported six-week
mortality only [10]. Statistically significant differences
were found in 3 of 7 studies that reported unadjusted p
values (Fig. 1b) [14, 19, 31]. Three studies presented re-
sults adjusted for demographic and clinical variables [10,
19, 31]; one study identified sites with statistically signifi-
cant higher mortality [31].
Fourteen studies reported on variation in LOS [10, 14–
18, 20–23, 25, 27, 28, 31]. The range in LOS variation (re-
ported by 12 studies) was 0 to 14.7 days (mean 4.83 days,
SD 3.89). Of nine studies reporting a range and p-value,
all found statistically significant variation (Fig. 2 and Add-
itional Table 1) [10, 14, 15, 18, 22, 23, 25, 28, 31]; six ad-
justed for confounders [10, 14, 15, 23, 25, 31]. One
additional study reported in text that following adjustment
for confounders the risk of having a LOS greater than the
mean for the study population was significantly increased
for two hospital sites by 2–3 fold [21].
The contribution of different factors towards variation
in LOS was examined by 4 studies, each comparing
inter-hospital variation (Table 2) [10, 14, 17, 22]. These
studies were able to account for 21–61% of the total ob-
served variation using statistical models adjusted for
hospital site and different patient and disease character-
istics. They found that the hospital of admission
accounted for between 1 and 24% of the observed
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variation in LOS. The proportion of the total variation
identified by each study due to hospital admission site (cal-
culated as the variation accounted for by hospital site / the
total variation accounted for by the model × 100) ranged
between 1.6–41.7%. No study adjusted the results for nat-
ural variation. Laing et al. attributed 26% of the observed
variation in LOS to process of care measures. Duration of
intravenous antibiotics and admission to ICU were also sig-
nificantly associated with LOS in that study [22].
Four studies examined whether variation in LOS was
associated with variation in other clinical outcomes;
none reported significant findings [10, 14, 15, 25]. Spe-
cifically, a shorter LOS was not associated with increased
mortality or readmission rates following multivariate
analysis in two studies [14, 25]. No study examined
post-discharge patient-reported outcome measures
(PROMs) in relation to LOS.
Seven studies reported variation in the proportion of pa-
tients requiring re-admission for any reason [14, 19, 22, 25,
27, 28, 31]; two from the same study population reporting
readmission at differing follow up points [19, 25]. Four
found statistically significant differences (Fig. 3) [14, 25, 27,
31]. All results were unadjusted, except those from Klausen
et al. who adjusted for gender, age, use of ventilatory sup-
port and Charlson index score, identifying three of 22 hos-
pitals with increased re-admission rates [31].
Fig. 1 a Inter-hospital variation in inpatient mortality across studies (%). Range represented as line, dot represents mean value where possible. *
denotes a statistically significant result. ^ denotes no reported p value. The letter ‘i’ represents an international study. The number in brackets
represents the number of units compared in the hospitals, unless otherwise stated. b- Inter-hospital variation in post discharge mortality across
studies (%) – 14 days post discharge or 30 days post admission. Range represented as line, dot represents mean value where possible. * denotes a
statistically significant result. ^ denotes no reported p value. The number in brackets represents the number of hospitals compared in the study,
unless otherwise stated
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Variation in process of care measures
A wide range of process of care measures were reported
across studies (Additional Table 2). Variation in the pro-
portion of patients admitted to ICU (n = 7 studies) was
found to be significantly different in the five studies that
reported p-values for this outcome [10, 14, 15, 17, 23,
25, 27]. Similarly, significant variation was observed in
the proportions with blood cultures obtained on admis-
sion (2 of 4 studies reported p-values; both p < 0.05) [12,
16, 27, 29]; receiving antibiotics within 8 h (2 of 4 studies
reported p-values; both p < 0.05) [12, 15, 16, 29] and
duration of intravenous antibiotics (4 of 5 studies re-
ported p values; all 4 p < 0.05) [14, 15, 17, 19, 22]. Seven
studies examined variation in adherence to antimicrobial
guidelines (4 of 7 studies reported p-values; 2 reported
p < 0.05) [15, 17, 22, 24, 27–29] while two studies exam-
ined variation in total antibiotic duration [15, 19]; one
found statistically significant variation [15]. Laing et al.
found significant variation in the duration of intravenous
antibiotic therapy between two hospitals with no ob-
served difference in mortality [22]. Following variance
analysis they accounted for 41% of the observed vari-
ation in IV antibiotic duration, attributing 24% to patient
characteristics, 4% to other management variables and
13% to hospital of admission (p < 0.001).
Discussion
Of the three primary outcome measures of interest, we
found consistent evidence for significant variation in re-
lation to LOS, but not mortality or hospital readmission
rates. There was consistent evidence for inter-hospital
variation in all process of care measures examined, how-
ever evidence linking variation in outcomes with vari-
ation in process of care measures was limited.
The evidence for variation in LOS was consistent
across studies and maintained following case-mix adjust-
ment for patient and disease factors. Despite this, rea-
sons for variation were not identified. Only one study
was able to account for over 30% of the total observed
variation [22]. Residual unaccounted variation may be
attributed to i) unmeasured factors not included in the
statistical models used or ii) natural variation due to
Fig. 2 Inter-hospital variation in average LOS in days across studies where reported. Range represented as line, dot represents mean value where
possible. * denotes a statistically significant result. ^ denotes no reported p value. The number in brackets represents the number of hospitals
compared in the study, unless otherwise stated
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chance. Multiple factors affect LOS, many of which were
unmeasured within the studies (eg. physician behaviour,
local healthcare system infrastructure) or competitively
effect the direction of association (eg. better quality of
care leading to survival of higher severity patients and
ultimately a longer LOS). None of the studies used a
statistical methodology to quantify or allow for natural
variation in their analysis of LOS. Therefore, despite
consistent evidence for variation, it is not possible to
quantify what proportion is due to true differences be-
tween units rather than chance.
We observed significant variation in in-patient mortal-
ity only in larger studies comparing five or more units.
Where variation in mortality was observed, care in the
interpretation of results is warranted as adequate adjust-
ment for both case-mix and natural variation were lim-
ited. In addition, none of the studies in this review
adjusted for social deprivation; a recognised major deter-
minant of inequalities in health, including mortality. In a
UK community study, 80% of the regional variation in
mortality from lower respiratory tract infections was
accounted for by socio-demographic factors, as mea-
sured by the Index of Multiple Deprivation [32].
Only one study used a statistical method to control for
the effect of natural variation when assessing variation in
mortality; namely the Spiegaelhalter method used by
Aelvoet et al. This method to identify outlying perform-
ing hospitals has been used elsewhere in national audit
programmes to examine variation in healthcare [33]. It
is an alternative method to reliability adjustment in
removing the ‘chance’ element from the analysis of vari-
ation. As a graphical method for assessing variation in
outcomes it has advantages over institutional ranking as it
plots where institutions lie within the 95% (2 standard de-
viation) and 99.8% (3 standard deviation) predication
limits around the mean. It can identify institutions that
consistently lie outside these limits for further investiga-
tion. It incorporates the institutional sample size into the
funnel plots as a measure of reliability of each institutional
prediction. Aelvoet et al. identified providers with consist-
ently outlying results within their single country study
suggesting true variation in mortality from CAP. Outside
this study, it is difficult to quantify from available evidence
the proportion of observed variation in mortality that is
due to true differences between units.
Outcome measures are increasingly used to rank insti-
tutions inevitably giving the appearance of ranking qual-
ity of care [4]. Rankability measures the proportion of
the variation between providers with regards to an out-
come that is due to true differences; it is considered high
if above 70% [34]. No study in this review directly
assessed the rankability of LOS as an outcome measure
in CAP. The proxy measure generated in this review
suggests a low rankability of < 50% across studies sug-
gesting caution should be applied when making infer-
ences about quality of care by ranking hospitals due to
variation in LOS.
Although mortality is an important clinical out-
come, it is a relatively infrequent outcome even in
adults hospitalised with CAP; occurring in 10–15% of
Table 2 Contribution of hospital of admission to Variation in Length of Stay
Study Number of
hospitals
Adjusted for P value Total Variation
accounted for by
the model (%)
Variation accounted
for by hospital site (%)
Proportion of total
variation accounted
for by the model
due to hospital site (%)
Cabre et al. 2007 [14] 27 PSI risk class, Complications
during hospitalisation,
Admission to ICU, Oxygen
therapy, Discharge to a NH
< 0.001 28.99 12 41.5
Feagan et al. 2000 [17] 20 PSI, Smoking status, COPD or
asthma, Bacterial pneumonia
Not
reported
21 7 33.3
Fine et al. 1993 [10] 4 PSI risk class, Age, NH resident,
Race, Bacteraemia, Serum
sodium <= 130mmol/l,
Hematocirt < 0.295, BUN > =
10.7 mmol/l
< 0.0001 24 10 41.7
Laing et al. 2004 [22] 2 Patient factors:
Age, Duration of fever, COPD,
PSI, Cerebrovascular disease,
Complications of pneumonia,
Heart failure, Ethnicity,
Bacteraemia, Diabetes
Process of care measures:
Duration of IV antibiotics,
Admission to ICU, Antibiotic
guideline adherence, Macrolide
and beta-lactam
< 0.01 61
Of which:
Patient factors – 34
POC measures – 26
1 1.6
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cases overall [35]. Small sample size and low event
rates limit the statistical power to compare between
hospitals [36]. Therefore, unless large sample sizes are
obtained, mortality may be an insensitive marker to
detect variation in care.
Many studies found CAP-related process of care mea-
sures to vary across hospitals. Evidence from observa-
tional studies suggests an association between selected
clinical outcomes and certain process of care measures;
a lower mortality has been associated with both earlier
administration of antibiotics and obtaining blood cul-
tures on admission while a decreased LOS has been as-
sociated with both antibiotic administration within four
hours of admission and an appropriate switch from
intravenous to oral antibiotics [37, 38]. However, none
of the studies in this review were able to fully examine
the association between variation in process of care mea-
sures and variation in clinical outcomes.
Strengths and limitations
To overcome the lack of specific terminology identifying
studies reporting on healthcare variation, we adopted a
broad search criteria with additional hand searching of
references to identify relevant studies. The quality of
studies eligible for this review was moderate. However,
due to inconsistencies in the statistical measures used
across studies, meta-analysis was not possible and a
structured synthesis was constructed. Reporting of the
proportion of missing data and the subsequent handling
of these data was absent in several studies, potentially re-
ducing statistical power and introducing non-response
bias to these studies.
Publication bias with studies observing minimal vari-
ation remaining unpublished is an important limitation.
Such bias may account for the finding of variation in
LOS in all relevant included studies. The majority of in-
cluded studies were conducted in Europe or North
America. Findings cannot be directly applied to health
care systems in developing countries or other developed
countries. Due to limited study numbers, results of stud-
ies reporting regional and inter-hospital differences were
combined. Although limited to three studies, inter-
national differences in healthcare systems and popula-
tions served may bias results towards increasing
observed variation.
Implications
A key finding from this review is the need for more
studies with robust methodologies to inform practice
and policy in the future. The following recommenda-
tions are suggested:
 Future studies assessing the impact of healthcare
variation in clinically important outcomes for
patients hospitalised with pneumonia require large
granular datasets comprising multiple subunits (at
least 10, preferably > 20) each with representative
patient samples.
 Datasets should include both process of care and
detailed outcome data linked at a patient level.
Process of care measures should include choice and
duration of antibiotic therapy used.
 Linkage of datasets from multiple sources (eg.
routinely collected hospital data, national audit data,
Fig. 3 Inter-hospital variation in all cause readmission rates across studies. Range represented as line, dot represents mean value where possible. *
denotes a statistically significant result. ^ denotes no reported p value. The number in brackets represents the number of hospitals compared in
the study, unless otherwise stated. Data presented from McCormick et al. is 14-day post discharge readmission rates
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primary care data) to allow rigorous case mix
adjustment and assessment of the impact on
healthcare following hospital discharge (re-
consultation, further antibiotic prescription).
 Smaller exploratory studies of patient-centred out-
come measures, such as PROMs, to assess the wider
implications of variation from a patient perspective
may be warranted.
 Robust and consistent statistical methodology that
allows for natural variation should be used. The
Spiegaelhalter method, increasingly used in the UK
for national audit reports, is one suggested method
[33, 39].
 Ranking of outcome measures should be avoided
unless coupled with a valid assessment of rankability
of the outcome measure utilised.
Conclusions
In the management of adults hospitalised with CAP,
there is consistent evidence of moderate quality for vari-
ation in LOS and process of care measures but not for
in-patient mortality or hospital re-admission rates. Evi-
dence linking variation in outcomes with variation in
process of care measures was limited due to a lack of
relevant studies. The proportion of observed variation
due to chance is not quantified by existing evidence.
This review highlights the importance of quantifying this
in order to assess the validity of institutional (or re-
gional) ranking by healthcare outcomes as a marker of
quality of care in patients with CAP.
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